Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2019)

Corcept Therapeutics has disclosed Interest & Investment Income across 6 years of filings, most recently posting $1.1 million for Q1 2019.

• Interest & Investment Income for Q1 2019 came in at $1.1 million, up 273.13% year-over-year; the trailing twelve-month figure through Mar 2019 was $3.5 million (up 636.17% YoY), and the FY2022 annual result was $3.6 million, up 572.4% from the prior year.
• Interest & Investment Income came in at $1.1 million for Q1 2019 at Corcept Therapeutics, up from $1.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q1 2019 to a low of -$487000.0 in Q3 2016.
• The 4-year median for Interest & Investment Income is $188000.0 (2017), against an average of $255272.7.
• Across the five-year window, Interest & Investment Income jumped 117.66% in 2017 and jumped 782.56% in 2018, its largest moves.
• Corcept Therapeutics' Interest & Investment Income stood at -$410000.0 in 2016, then soared by 145.85% to $188000.0 in 2017, then surged by 454.26% to $1.0 million in 2018, then increased by 5.28% to $1.1 million in 2019.
• The last three Interest & Investment Income figures came in at $1.1 million (Q1 2019), $1.0 million (Q4 2018), and $759000.0 (Q3 2018), per Business Quant data.